News

A combination of a common immunotherapy drug with all-trans retinoic acid, a chemotherapeutic, has shown promise in clinical trials.

Researchers have identified that some cancer cells can “cheat” by escaping constraints imposed by hypoxia, allowing the cancer cells to continue to grow.

A new study has demonstrated a promising experimental therapy in preclinical models of an aggressive subtype of colorectal cancer.

Researchers have discovered how some cancers persist after chemo and why they don’t respond well to immunotherapies designed to clear out remaining tumor cells by revving up the immune system.

Researchers from the Tokyo Medical and Dental University have identified potential targets for drug development against pancreatic cancer.

A new personalized cancer vaccine has demonstrated efficacy against melanoma in a Phase IIb clinical trial.

A biomarker has been identified that can be used to predict the efficacy of a chemotherapeutic commonly used to treat breast cancer.

Focusing on breast cancer after menopause, a new study using mouse models suggests that obesity may cause previously dormant tumors to form new blood vessels, enabling them to grow and become more of a threat.

A murine study has revealed that in prostate cancer, the expansion of castration-resistant cells correlates with resistance to treatment and poor clinical outcomes in humans.

A single bout of exercise can raise the levels of myokines – proteins that are produced by skeletal muscles that can suppress cancer growth – in advanced cancers.